Shares of dental products maker Dentsply Sirona Inc. (XRAY) fell sharply by over 5% in pre-market trading on Thursday, February 27th, following the company's release of weaker-than-expected fourth-quarter 2024 earnings and disappointing guidance for 2025.
For the fourth quarter, Dentsply Sirona reported adjusted earnings per share of $0.26, significantly missing Wall Street's consensus estimate of $0.43. The company's revenue of $905 million also fell short of analysts' expectations of $920.56 million.
More concerning was the company's outlook for 2025. Dentsply Sirona projected adjusted earnings per share of $1.80 to $2.00, well below the consensus forecast of $1.91. Additionally, the company guided for revenue in the range of $3.5 billion to $3.6 billion, compared to analysts' expectations of $3.734 billion. This weaker guidance was attributed to an expected 2% to 4% decline in organic sales, including a 2% hit from its Byte clear aligner business.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.